Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly
Crossref DOI link: https://doi.org/10.1007/s12020-016-0895-8
Published Online: 2016-02-23
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schmid, Herbert A.
Brue, Thierry
Colao, Annamaria
Gadelha, Mônica R.
Shimon, Ilan
Kapur, Karen
Pedroncelli, Alberto M.
Fleseriu, Maria
Funding for this research was provided by:
Novartis Pharma AG
License valid from 2016-02-23